Nanobiosym

Meet an Unreasonable Venture

Using nanotechnology to empower people worldwide with rapid, affordable, and portable diagnostic information about their own health.

Anita Goel

Founder, Chairman, CEO at Nanobiosym

More about Anita »

Connect

nanobiosym.com

Employees 21–50

Headquarters Cambridge, Massachusetts, United States

Nanobiosym Diagnostics has built and is now commercializing its FDA-authorized platform for Personalized Precision Medicine called Gene-RADAR. Harnessing more than 20 years of award-winning science and technology at the convergence of physics, nanotechnology, ICT, and biomedicine, Nanobiosym Dx is working to decentralize, democratize, mobilize, and personalize the next generation of healthcare delivery. The company aims to empower 8 billion consumers with real-time personalized mobile diagnostics and exponentially increase access to accurate diagnostics for anyone, anywhere and at any time. This includes the 4 billion people people globally who currently lack access to information about their health. Nanobiosym is part research institute and part incubator, advancing the frontiers of nanobiophysics and harnessing these innovations with novel business models and public-private partnerships to address our planet’s greatest unmet needs.

Health

Elevator Pitch Pitch Video Unreasonable Impact COVID Response Summit

Subscribe for More Videos »

Press Mentions

October 29, 2024

20 Successful Startups Born at MIT [2024]

Nanobiosym, a groundbreaking company born at MIT, is revolutionizing healthcare with its innovative diagnostic technology. Celebrated for its rapid disease detection capabilities, Nanobiosym...

Read on DigitalDefynd »

November 1, 2020

Entrepreneurship As A Force For Good

Some businesses made rapid, meaningful pivots to addressing the crises caused by COVID-19. We can help them build a better future by continuing to support them after the immediate emergency has...

Read on The Atlantic »